<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
PE CORPORATION
(Exact Name of Registrant as Specified in Its Charter)
<TABLE>
<S> <C>
DELAWARE 06-1534213
(State of Incorporation or Organization) (I.R.S. Employer Identification Number)
761 MAIN AVENUE 06859-0001
NORWALK, CONNECTICUT (Zip Code)
(Address of Principal Executive Office)
If this form relates to the registration of a If this form relates to the registration of a
class of securities pursuant to Section 12(b) class of securities pursuant to Section 12(g)
of the Exchange Act and is effective pursuant of the Exchange Act and is effective pursuant
to General Instruction A.(c), please check to General Instruction A.(d), please check
the following box. /X/ the following box. / /
SECURITIES ACT REGISTRATION STATEMENT FILE NUMBER TO WHICH THIS FORM RELATES: 333-67797
(if applicable)
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(B) OF THE ACT:
</TABLE>
<TABLE>
<CAPTION>
TITLE OF EACH CLASS NAME OF EACH EXCHANGE ON WHICH
TO BE SO REGISTERED: EACH CLASS IS TO BE REGISTERED:
- ----------------------------------------------- -----------------------------------------------
<S> <C>
PE Corporation-PE Biosystems Group Common New York Stock Exchange
Stock, par value $.01 per share Pacific Stock Exchange
Rights to Purchase Series A Participating New York Stock Exchange
Junior Preferred Stock, par value $.01 per Pacific Stock Exchange
share
PE Corporation-Celera Genomics Group Common New York Stock Exchange
Stock, par value $.01 per share Pacific Stock Exchange
Rights to Purchase Series B Participating New York Stock Exchange
Junior Preferred Stock, par value $.01 per Pacific Stock Exchange
share
SECURITIES TO BE REGISTERED PURSUANT TO SECTION 12(G) OF THE ACT:
None.
</TABLE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
INFORMATION REQUIRED IN REGISTRATION STATEMENT
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
Descriptions of PE Corporation--PE Biosystems Group Common Stock, PE
Corporation--Celera Genomics Group Common Stock, the Rights to Purchase Series A
Participating Junior Preferred Stock and the Rights to Purchase Series B
Participating Junior Preferred Stock are contained in the Registrant's
Registration Statement on Form S-4 (File No. 333-67797) (the "Form S-4
Registration Statement") and are incorporated herein by reference.
ITEM 2. EXHIBITS.
1. Certificate of Incorporation of the Registrant (incorporated by
reference from Exhibit 3.1 to the Form S-4 Registration Statement).
2. By-laws of the Registrant (incorporated by reference from Exhibit 3.2 to
the Form S-4 Registration Statement).
3. Certificate of Designations for the Series A Participating Junior
Preferred Stock and the Series B Participating Junior Preferred Stock
(incorporated by reference from Exhibit 3.3 to the Form S-4 Registration
Statement).
4. Rights Agreement between the Registrant and BankBoston, N.A., as Rights
Agent (incorporated by reference from Exhibit 4.1 to the Form S-4
Registration Statement).
2
<PAGE>
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereto duly authorized.
PE CORPORATION
By: /s/ THOMAS P. LIVINGSTON
- --------------------------------------------------------------------------------
Name: Thomas P. Livingston
Title: Assistant Secretary
Date: February 2, 1999.
3
